...
首页> 外文期刊>Journal of Thoracic Disease >Clinical analyses on salvage lymphadenectomy through cervical incision for patients with cervical and cervicothoracic recurrences after esophagectomy
【24h】

Clinical analyses on salvage lymphadenectomy through cervical incision for patients with cervical and cervicothoracic recurrences after esophagectomy

机译:食管切除术后宫颈切口宫颈切开术治疗宫颈切口临床分析

获取原文
           

摘要

Background: Locoregional recurrences are often observed after esophagectomy with lymphadenectomy. The treatment strategy for these patients has not been established completely. The purpose of this study was to evaluate the prognosis of salvage lymphadenectomy through the cervical incision for cervical and cervicothoracic recurrences. Methods: We retrospectively reviewed patients underwent initial esophagectomy and then salvage lymphadenectomy in Fudan University Shanghai Cancer Center during July 2006 and September 2016. Survival curve was calculated by Kaplan-Meier method. Prognostic factors for post-salvage lymphadenectomy overall survival (PSL-OS) were identified by univariate and multivariate analyses. Results: The median disease-free survival (DFS) was 8 months. The median PSL-OS was 40 months (95% CI 8.850–71.150). The 1-, 2-, 3- and 5-year PSL-OS rate were 87%, 58%, 52% and 41%, respectively. Univariate and multivariate analyses confirmed the initial TNM stage was the only independent prognostic factor for PSL-OS (P=0.000 by log-rank test, P=0.009 by Cox hazards model, HR 3.999, 95% CI 1.413– 11.316) among these patients. Conclusions: PSL survival could be considerable for patients with early initial tumor stage. Prospective studies are warranted to clarify the value of salvage lymphadenectomy.
机译:背景:淋巴结切除术后食管切除术后经常观察到型患者复发。这些患者的治疗策略尚未完全建立。本研究的目的是通过宫颈切口进行宫颈切口来评估挽救淋巴结切除术的预后。方法:我们回顾性地审查了初期食管切除术的患者,然后在2006年7月和2016年9月举行的复旦大学上海癌症中心挽救淋巴结切除术。通过Kaplan-Meier方法计算生存曲线。通过单变量和多变量分析鉴定了拯救后淋巴结切除术后总存活(PSL-OS)的预后因素。结果:中位病人存活(DFS)为8个月。中位数PSL-OS为40个月(95%CI 8.850-71.150)。 1-,2-,3-和5年PSL-OS率分别为87%,58%,52%和41%。单变量和多变量分析证实了初始TNM阶段是PSL-OS的唯一独立的预后因素(通过对数秩检验P = 0.000,P = 0.009通过Cox危险模型,HR 3.999,95%CI 1.413-11.316)在这些患者中。结论:PSL存活率对于早期初始肿瘤阶段的患者可能相当大。经验预期研究是为了澄清挽救淋巴结切除术的价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号